Central Virginia

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

Albemarle County's initiative to bring more federal intelligence agency activity to Rivanna Station includes academic engagement from UVA.

A new way of thinking about Alzheimer's disease has yielded a UVA research discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.

PS Fertility leverages patent pending research work on male fertility and cellular biology done at the University of Virginia Medical School.

UVA's School of Continuing and Professional Studies offers a program for busy public sector professionals who are eager to dive into hot topics related to Artificial Intelligence and the local government.

The Innovation Award honors breakthrough product development that significantly improves election verification and auditing. The program provides hands-on training and unmatched real-world experience.

Shen's new venture is providing artificial intelligence-based tools for telecom engineers in a space called ORAN, which is short for open radio access network.

UVA-affiliated startup BrightSpec launched the world's first commercial Molecular Rotational Resonance (MRR) instruments in 50 years. The team received a PittCon Today Excellence Award in recognition of their innovation and the impact of their new…

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

Starting from the campus of the University of Virginia, AgroSpheres has created a comprehensive biomodality platform, injecting strong momentum into the sustainable development of global agriculture.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.